Disease areas:
  • infections
Last updated:
Author(s):
Jakob Steinfeldt, Benjamin Wild, Thore Buergel, Maik Pietzner, Julius Upmeier zu Belzen, Andre Vauvelle, Stefan Hegselmann, Spiros Denaxas, Harry Hemingway, Claudia Langenberg, Ulf Landmesser, John Deanfield, Roland Eils
Publish date:
10 January 2025
Journal:
Nature Communications
PubMed ID:
39794311

Abstract

The COVID-19 pandemic exposed a global deficiency of systematic, data-driven guidance to identify high-risk individuals. Here, we illustrate the utility of routinely recorded medical history to predict the risk for 1741 diseases across clinical specialties and support the rapid response to emerging health threats such as COVID-19. We developed a neural network to learn from health records of 502,489 UK Biobank participants. Importantly, we observed discriminative improvements over basic demographic predictors for 1546 (88.8%) endpoints. After transferring the unmodified risk models to the All of US cohort, we replicated these improvements for 1115 (78.9%) of 1414 investigated endpoints, demonstrating generalizability across healthcare systems and historically underrepresented groups. Ultimately, we showed how this approach could have been used to identify individuals vulnerable to severe COVID-19. Our study demonstrates the potential of medical history to support guidance for emerging pandemics by systematically estimating risk for thousands of diseases at once at minimal cost.

Related projects

Genetic contributions to many health-related phenotypes like blood pressure and body mass index often arise from complex interactions between multiple genes. While there are diseases…

Institution:
Charite - Universitatsmedizin Berlin, Germany

Cardiovascular diseases are the leading cause of death globally. In cardiovascular disease, an early detection results in less complications and better prognosis. Currently, disease detection…

Institution:
Charite - Universitatsmedizin Berlin, Germany

All projects